189 related articles for article (PubMed ID: 36683090)
1. Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study.
Langley C; Armand S; Luo Q; Savulich G; Segerberg T; Søndergaard A; Pedersen EB; Svart N; Overgaard-Hansen O; Johansen A; Borgsted C; Cardinal RN; Robbins TW; Stenbæk DS; Knudsen GM; Sahakian BJ
Neuropsychopharmacology; 2023 Mar; 48(4):664-670. PubMed ID: 36683090
[TBL] [Abstract][Full Text] [Related]
2. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
4. Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study.
Armand S; Langley C; Johansen A; Ozenne B; Overgaard-Hansen O; Larsen K; Jensen PS; Knudsen GM; Sahakian BJ; Stenbæk DS; Fisher PM
Sci Rep; 2024 Feb; 14(1):3149. PubMed ID: 38326352
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
6. Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.
Skandali N; Rowe JB; Voon V; Deakin JB; Cardinal RN; Cormack F; Passamonti L; Bevan-Jones WR; Regenthal R; Chamberlain SR; Robbins TW; Sahakian BJ
Neuropsychopharmacology; 2018 Dec; 43(13):2645-2651. PubMed ID: 30305705
[TBL] [Abstract][Full Text] [Related]
7. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Wingen M; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
[TBL] [Abstract][Full Text] [Related]
8. Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
Mischoulon D; Shelton RC; Baer L; Bobo WV; Curren L; Fava M; Papakostas GI
J Clin Psychiatry; 2017 Apr; 78(4):449-455. PubMed ID: 27835715
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study.
Drueke B; Baetz J; Boecker M; Moeller O; Hiemke C; Gründer G; Gauggel S
Psychopharmacology (Berl); 2009 Dec; 207(2):213-23. PubMed ID: 19756527
[TBL] [Abstract][Full Text] [Related]
10. The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls.
Lochner C; Chamberlain SR; Kidd M; Taljaard L; Fineberg NA; Robbins TW; Stein DJ
Psychopharmacology (Berl); 2020 Oct; 237(10):3117-3123. PubMed ID: 32638035
[TBL] [Abstract][Full Text] [Related]
11. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
[TBL] [Abstract][Full Text] [Related]
13. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of escitalopram challenge on disgust processing in obsessive-compulsive disorder.
Lochner C; Simmons C; Kidd M; Chamberlain SR; Fineberg NA; van Honk J; Ipser J; Stein DJ
Behav Brain Res; 2012 Jan; 226(1):274-80. PubMed ID: 21963422
[TBL] [Abstract][Full Text] [Related]
15. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial.
Knorr U; Koefoed P; Gluud C; Wetterslev J; Winkel P; Gether U; Vinberg M; Kessing LV
Nord J Psychiatry; 2016; 70(4):297-302. PubMed ID: 26752119
[TBL] [Abstract][Full Text] [Related]
16. Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval.
Reed MB; Vanicek T; Seiger R; Klöbl M; Spurny B; Handschuh P; Ritter V; Unterholzner J; Godbersen GM; Gryglewski G; Kraus C; Winkler D; Hahn A; Lanzenberger R
Neuroimage; 2021 Aug; 236():118039. PubMed ID: 33852940
[TBL] [Abstract][Full Text] [Related]
17. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
19. Comparing escitaloipram with sertraline for obsessive and compulsive symptoms in patients with obsessive compulsive disorder: A comparative double blind clinical trial.
Mowla A; Modarresi F; Dastgheib SA
Asian J Psychiatr; 2018 Dec; 38():92-95. PubMed ID: 29158148
[TBL] [Abstract][Full Text] [Related]
20. The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.
Tõru I; Maron E; Raag M; Vasar V; Nutt DJ; Shlik J
Eur Neuropsychopharmacol; 2013 Jul; 23(7):645-52. PubMed ID: 22939006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
